Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Als crawled date : 2022 - 02 - 28 save search
Fusion Pharmaceuticals to Participate at the Cowen 42nd Annual Health Care Conference
Published: 2022-02-28 (Crawled : 23:00) - biospace.com/
FUSN | $21.42 0.47% 0.47% 1.9M
|
Health Technology
|
| O: 0.33%
H: 3.93%
C: -1.64%
health als conference
Zynerba Pharmaceuticals Announces European Commission Has Granted Orphan Drug Designation for Zygel™ in Fragile X SyndromeProvides 10-year market exclusivity in EU upon regulatory approval
Published: 2022-02-28 (Crawled : 23:00) - biospace.com/
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: -4.76%
H: 0.0%
C: 0.0%
als europe drug granted approval drug designation orphan drug grant designation zygel
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-28 (Crawled : 23:00) - biospace.com/
APLS G | $48.72 2.27% 2.16% 940K
|
Health Technology
|
| O: -0.07%
H: 0.61%
C: 0.07%
als financial results report results
Varian Biopharmaceuticals, Inc. and SPK Acquisition Corp. Announce Release of Investor Presentation Regarding Previously Announced Merger; Provide Corporate Update
Published: 2022-02-28 (Crawled : 23:00) - globenewswire.com
SPK 4 | $10.3 0.49% 0.19%
|
| Email alert
Add to watchlist
als biopharma acquisition presentation acquisition corp merge
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-28 (Crawled : 22:00) - biospace.com/
ACAD | News | $16.74 -1.47% -1.52% 1.5M
|
Health Technology
|
| O: -0.7%
H: 1.1%
C: -0.2%
als financial results report results
HYSTER-YALE MATERIALS HANDLING ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 RESULTS
Published: 2022-02-28 (Crawled : 22:00) - prnewswire.com
HY 4 | $61.61 2.51% 0.0% 140K
|
Producer Manufacturing
|
| O: -1.52%
H: 0.0%
C: -10.69%
als ces results
Zynerba Pharmaceuticals Announces European Commission Has Granted Orphan Drug Designation for Zygel™ in Fragile X Syndrome
Published: 2022-02-28 (Crawled : 21:00) - zynerba.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 0.91%
H: 3.38%
C: -2.7%
als europe drug granted drug designation orphan drug grant syndros designation zygel
Edenbridge Pharmaceuticals Announces the Launch of DARTISLA ODT
Published: 2022-02-28 (Crawled : 20:00) - biospace.com/
CTLT | $56.03 -0.04% -0.78% 1.3M
|
Health Technology
|
| O: -0.96%
H: 0.83%
C: 0.66%
als ces dart
The CUMULUS MEDIA | Westwood One Audio Active Group® Reveals New Advertiser and Consumer Studies on Media Attentiveness and Ad Skipping
Published: 2022-02-28 (Crawled : 18:00) - globenewswire.com
CMLS | $2.7 0.92% 68K
|
Consumer Services
|
| O: -0.09%
H: 6.46%
C: 5.72%
group als audio media active one
Duke Realty Secures Multiple Lease Deals in Texas, Dallas Portfolio 100% Leased
Published: 2022-02-28 (Crawled : 17:00) - dukerealty.com
DRE | $48.2 0.0%
|
Finance
|
| O: -1.08%
H: 0.26%
C: -0.6%
als deal 100
Thermo Fisher Scientific Calls for Grant Proposals to Support Research in Cancer Molecular Profiling
Published: 2022-02-28 (Crawled : 16:00) - biospace.com/
TMO | News | $574.59 4.78% 3.34% 2.2M
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: 0.0%
als research molecular cancer grant granted
Tonix Pharmaceuticals Announces Research Agreement with the French National Institute of Health and Medical Research (Inserm) to Study the Mechanism of Oxytocin-Mediated Improvement of Eating Behaviors in Prader-Willi Mice
Published: 2022-02-28 (Crawled : 15:00) - biospace.com/
TNXP | $0.1568 0.9% 1.27% 1.6M
|
Health Technology
|
| O: 1.2%
H: 6.32%
C: 4.4%
health als research media oxytocin ism
Pause of GSK's RSV Vaccine Trials in Pregnant Women Deepens
Published: 2022-02-28 (Crawled : 15:00) - biospace.com/
JNJ | News | $149.56 0.3% -0.17% 6.9M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
als trials trial women vaccine
Zynerba Pharmaceuticals Announces Completion of Enrollment in Phase 2 Trial of Zygel™ in 22q11.2 Deletion SyndromeTopline data from Phase 2 INSPIRE trial expected mid-year 2022
Published: 2022-02-28 (Crawled : 14:30) - biospace.com/
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: -4.76%
H: 0.0%
C: 0.0%
phase 2 als trial topline enroll zygel
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Study of LNK01001 in Patients with Atopic Dermatitis
Published: 2022-02-28 (Crawled : 14:30) - biospace.com/
JNJ | News | $149.56 0.3% -0.17% 6.9M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
lnk0100 als atopic dermatitis ces dermatitis derm 100
Seelos Therapeutics Announces Dosing of the First Participants in a Registrational Phase II/III Trial of SLS-005 in Amyotrophic Lateral Sclerosis on the HEALEY ALS Platform
Published: 2022-02-28 (Crawled : 14:00) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: -0.94%
H: 5.71%
C: 0.95%
sls-005 als trial therapeutics sclerosis platform
Zynerba Pharmaceuticals Announces Completion of Enrollment in Phase 2 Trial of Zygel™ in 22q11.2 Deletion Syndrome
Published: 2022-02-28 (Crawled : 13:30) - zynerba.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: -4.76%
H: 0.0%
C: 0.0%
phase 2 als trial syndros enroll zygel
Spectrum Pharmaceuticals Announces an Oral Poziotinib Presentation at the Upcoming ESMO TAT 2022 Virtual Meeting
Published: 2022-02-28 (Crawled : 13:30) - biospace.com/
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: -1.24%
H: 3.22%
C: -3.19%
als ces poziotinib presentation iot
Adamis Pharmaceuticals’ Clinical Study Assessing Tempol for the Treatment of COVID-19 Surpasses Enrollment Expectations
Published: 2022-02-28 (Crawled : 13:30) - biospace.com/
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: 1.62%
H: 3.23%
C: 1.6%
covid-19 treatment als covid enroll
The Metals Company Welcomes Growing Recognition from Political and Military Leaders of Deep-Sea Nodules’ Potential to Strengthen National Security and Reshore Supply Chains for the Clean Energy Transition
Published: 2022-02-28 (Crawled : 13:30) - globenewswire.com
TMC A | $1.66 1.22% 0.61% 1.3M
|
|
| O: -4.02%
H: 5.99%
C: 3.59%
als security energy potential growing
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
Your saved searches
Save your searches and get alerts when important news are released.